These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 33725760)

  • 1. Ciprofloxacin-induced cutaneous adverse drug events: a systematic review of descriptive studies.
    Kashyap A; Sreenivasan S; Rajan AK; Rashid M; Chhabra M
    J Basic Clin Physiol Pharmacol; 2021 Mar; 33(3):327-346. PubMed ID: 33725760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam and cutaneous adverse reactions: A systematic review of descriptive studies.
    Rashid M; Rajan AK; Chhabra M; Kashyap A
    Seizure; 2020 Feb; 75():101-109. PubMed ID: 31931437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between HLA-B*1301 and Dapsone-Induced Cutaneous Adverse Drug Reactions: A Systematic Review and Meta-analysis.
    Tangamornsuksan W; Lohitnavy M
    JAMA Dermatol; 2018 Apr; 154(4):441-446. PubMed ID: 29541744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs and the skin: A concise review of cutaneous adverse drug reactions.
    Del Pozzo-Magaña BR; Liy-Wong C
    Br J Clin Pharmacol; 2024 Aug; 90(8):1838-1855. PubMed ID: 35974692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metronidazole Induced Cutaneous Adverse Drug Reaction- A Systematic Review of Descriptive Studies.
    Taj S; Zuber M; Hanumanthaiah VB; Venkataraman R; Puttegowda SK; Afrid S; Kiran S
    Curr Rev Clin Exp Pharmacol; 2024; 19(3):269-284. PubMed ID: 37264661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse cutaneous drug reactions among hospitalized patients: five year surveillance.
    Turk BG; Gunaydin A; Ertam I; Ozturk G
    Cutan Ocul Toxicol; 2013 Mar; 32(1):41-5. PubMed ID: 22812902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous adverse drug reactions in Indian population: A systematic review.
    Patel TK; Thakkar SH; Sharma D
    Indian Dermatol Online J; 2014 Dec; 5(Suppl 2):S76-86. PubMed ID: 25593813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Study of Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Andhra Pradesh, India.
    Ashifha S; Vijayashree J; Vudayana K; Chintada D; P P; G P; Unnikrishnan P
    Cureus; 2023 Apr; 15(4):e37596. PubMed ID: 37197134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin-Induced Bullae of the Lower Extremity: A Case of a Fixed Drug Reaction.
    Mollica AJ; Mollica AJ; Grant E; Malik A; Claydon M
    J Am Podiatr Med Assoc; 2019 Mar; 109(2):155-158. PubMed ID: 31135195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin-induced generalised non-bullous fixed drug eruption.
    Iliyas M; Ram Subba Reddy M; Devi U
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29866687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nevirapine: Most Common Cause of Cutaneous Adverse Drug Reactions in an Outpatient Department of a Tertiary Care Hospital.
    Pawar MP; Pore SM; Pradhan SN; Burute SR; Bhoi UY; Ramanand SJ
    J Clin Diagn Res; 2015 Nov; 9(11):FC17-20. PubMed ID: 26672558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic markers associated with cutaneous adverse drug reactions to allopurinol: a systematic review.
    Jarjour S; Barrette M; Normand V; Rouleau JL; Dubé MP; de Denus S
    Pharmacogenomics; 2015; 16(7):755-67. PubMed ID: 25965122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Cutaneous Adverse Drug Reactions (ADR) Reported at an ADR Monitoring Center of a Tertiary Care Teaching Institute in Central India.
    Chindhalore CA; Gupta AV; Dakhale GN; Srivastava A
    Cureus; 2024 Feb; 16(2):e53706. PubMed ID: 38455795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DRESS syndrome with mild manifestations as a diagnostic and therapeutic problem: case report.
    Artuković M; Kustelega J; Lugović-Mihić L
    Acta Clin Croat; 2010 Dec; 49(4):479-84. PubMed ID: 21830461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermoscopic Aspects of Cutaneous Adverse Drug Reactions.
    Rossi G; da Silva Cartell A; Marchiori Bakos R
    Dermatol Pract Concept; 2021 Jan; 11(1):e2021136. PubMed ID: 33614215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical profile of cutaneous adverse drug reactions: a retrospective study of 1883 hospitalized patients from 2007 to 2016 in Shanghai, China.
    Yang F; Chen Z; Chen SA; Zhu Q; Wang L; Xiong H; Fu H; Luo X
    Eur J Dermatol; 2020 Feb; 30(1):24-31. PubMed ID: 32031529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of cutaneous adverse drug reactions among medical inpatients of Sultanah Aminah Hospital Johor Bahru.
    Latha S; Choon SE
    Med J Malaysia; 2017 Jun; 72(3):151-156. PubMed ID: 28733562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions.
    Hassoun-Kheir N; Bergman R; Weltfriend S
    Int J Dermatol; 2016 Nov; 55(11):1219-1224. PubMed ID: 27368159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in culprit drugs and clinical entities in cutaneous adverse drug reactions: a retrospective study.
    Wang F; Zhao YK; Li M; Zhu Z; Zhang X
    Cutan Ocul Toxicol; 2017 Dec; 36(4):370-376. PubMed ID: 28423957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous adverse drug reactions with fixed-dose combinations: Special reference to self-medication and preventability.
    Tripathy R; Pattnaik KP; Dehury S; Patro S; Mohanty P; Sahoo SS; Mohanty S
    Indian J Pharmacol; 2018; 50(4):192-196. PubMed ID: 30505055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.